cyclophosphamide,ytb323,rapcabtagene autoleucel,fludarabine
novartis,novartis,Bayer
['fludarabine', 'rapcabtagene', 'cyclophosphamide', 'lymphoma', 'ytb323', 'dlbcl', '$nvs']
with t-charge $nvs can manufacture ytb323 (rapcabtagene autoleucel) in just 2 days so patients can be treated in ~78 days rather than the usual ~90 days #ash22 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.